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The radiation field of heavy-ion beams used for radiotherapy applications is significantly affected by 
nuclear fragmentation processes along the penetration path in tissue, causing an attenuation of the primary 
ion beam flux and the build-up of light fragments including fast neutrons. The emission of secondary 
fragments from 200 MeV/u carbon ions delivered from the synchrotron SIS-18 at GSI was investigated 
using a water absorber as tissue-equivalent beam stopping target. Energy spectra, angular distributions 
and yields of fast neutrons and charged particles emerging from the absorber downstream were 
investigated by using fast scintillation detectors and time-of-flight techniques. From the resulting yield of 
0.54 neutrons (En>10 MeV) per primary 12C ion a neutron dose of 5.4 mSv per Cobalt Gray Equivalent 
(GyE) delivered to the target volume is estimated. Additional measurements employing a wide-energy 
neutron detector (WENDI-II) under identical irradiation conditions were found to be in fair agreement 
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Carbon ions offer favorable conditions for the treatment of deep-seated, localized tumors due to 
their physical and biological properties. Their dose profile is - in contrast to photons – inverted, 
the dose maximum is deposited at the end of the particle range in the so called “Bragg peak”. In 
addition the relative biological effectiveness (RBE) of carbon ions increases in the region of the 
Bragg peak by a factor of three to five. Nuclear reactions along the penetration path, however, 
cause a significant alteration of the radiation field. At energies of several hundred MeV/u which 
are required for radiotherapy the most frequent nuclear interactions are peripheral collisions 
where the beam particles loose one or several nucleons. The fragments continue travelling with 
nearly the same velocity and direction. These nuclear reactions lead to an attenuation of the 
primary beam flux and a build-up of lower-Z fragments with increasing penetration depth. As 
the range of the particles scales with A/Z2 the depth-dose profile of heavy-ion beams shows a 




Figure 1: Bragg curve of 200 MeV/u 12C ions in water. The data points (red) are shown 
together with a Monte-Carlo calculation using the PHITS code [1]. The calculated  
contributions of primary ions and secondary fragments are indicated. The right part 
shows a magnified view of the dose tail behind the Bragg peak. 
 
 
The attenuation of the primary particle flux and build-up of lower-Z charged fragments 
along the penetration path in water were studied earlier at LBL Berkeley [2], at GSI Darmstadt 
[3] and at the HIMAC facility at Chiba [4]. For the production of neutrons in thick targets, 
however, the experimental data are rather scarce and mainly concern the design of shielding 
components for accelerators or space missions.  Neutron production by fragmentation of light 
ions, like helium ions in water was investigated by Cecil et al.[5] and more recently, neutrons 
produced  from carbon ion beams stopped in graphite targets by Kurosawa et al.[6]. Here we 
report on measurements [7] of the fast neutron component produced by nuclear fragmentation of 
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2. Spectral measurements of fast neutrons produced from 200 MeV/u 12C ions                            
A pencil-like beam of 200 AMeV 12C ions was stopped in a 12.78 cm thick water target. 
The range of the primary particles is 8.6 cm, corresponding to 67% of the target thickness (see 
Fig.1). Light beam fragments emerging in forward direction from the water target were detected 
by a ∆E-E-telescope in about 3 m distance from the target and at angles between 0º to 30º 
degrees with respect to the beam axis. The telescope consisted of a 14 cm long, hexagonally 
shaped BaF2 scintillator and a 9 mm thick NE102 scintillator (veto detector) in front to 
discriminate charged particle and neutron events. The veto scintillator had an inscribed radius of 
5.4 cm, the BaF2 crystal of 4.5 cm. Particle energies were measured by time-of-flight 
techniques. A thin NE102 scintillator in front of the target counted the number of the incoming 
12C ions and delivered the start signal for the time-of flight measurement. The stop signal was 
obtained from the BaF2 detector. The nuclear charge and mass of the particles were identified by 
the correlation of their energy lost in the veto scintillator and their energy deposited in the BaF2 
detector. The neutron efficiency of the BaF2 detector was obtained from separate measurements 
[8] using quasi-monoenergetic neutron beams at UCL Louvain (Belgium) and iThemba LABS 
(South Africa). 
The energy spectra and angular distributions of neutrons emerging from the water target at 
angles of 0º, 5º, 10º, 20º and 30º are shown in Figs. 2 and 3. Neutrons are mainly emitted in 
forward direction and a broad maximum can be observed at about half of the initial beam energy 
at small angles (0º and 5º),  indicating a strong contribution of projectile abrasion in peripheral 
collisions. The spectra measured at 10º, 20º and 30º have an exponential shape, which is typical 
for individual high energy nucleons and fragments evaporated from the hot reaction zone. From 
0º to 30º a significant fraction of the neutron energy spectra extends to energies greater than 200 




Figure 2: Neutron energy spectra measured at 
various angles with respect to the beam axis. 
The arrow indicates the energy of the primary 
12C ions. The solid lines represent calculations 
with the Monte-Carlo code PHITS [1]. 
 
 
Figure 3:  Angular distributions of fast 
neutrons and charged fragments (normalized 
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In order to obtain the yields of secondary neutrons and charged fragments in the forward 
hemisphere the angular distributions were extrapolated to 90° and integrated. The results are 
shown in Table 1 together with estimated doses values (see section 3).  
 














Table 1: Total particle yields (E > 10 MeV) in the forward hemisphere and the 
corresponding estimated dose per treatment Gray. 
 
3.  Estimation of the neutron dose in patient treatments with carbon ions 
Based on the measured neutron yield for 200 MeV/u 12C ions stopping in water the dose 
contribution of secondary fast neutrons in patient treatments with carbon ions was estimated by 
converting the neutron fluence into kerma (kinetic energy released per mass unit). As a typical 
treatment volume the irradiation of a cube with the side length of 5 cm, i.e. an irradiated area of 
25 cm2, was assumed. To apply 20 Gy absorbed dose (corresponding to about 60 GyE 
biologically effective dose) to the given volume, a total amount of 5·1010 carbon ions is 
required. This number is obtained from the computer code TRiP [9] which is routinely used for 
patient treatment planning at GSI. The biologically effective dose given in units of Cobalt Gray 
Equivalent (GyE) includes the relative biological effectiveness (RBE) of the particles. Because 
of the complex composition of the particle field due to nuclear fragmentation, however, the 
biologically effective dose is not a simple product of absorbed dose and a mean RBE value but 
is evaluated by an iterative procedure using the TRiP code [10].     
Taking the neutron yield of 0.54/ion, the neutron fluence 4 cm behind the irradiated 
volume then amounts to (1.1±0.4)·109 neutrons/cm2. (The distance of 4 cm corresponds to the 
difference of target thickness and ion beam range in our measurements.) The kerma coefficient 
in water recommended in the ICRP 63 was extrapolated to a neutron energy of 200 MeV 
(k=150 pGy·cm2) and multiplied with the fluence Φ(E) to obtain the neutron kerma. The 
resulting neutron dose of 8 mGy per treatment-Gy (table 1) is less then 1% of the treatment 
dose. This result is in good agreement with recent calculations [11] based on the Monte-Carlo 
code GEANT4.  
Alternatively, the neutron dose equivalent (as defined in medical physics) can be estimated 
by multiplying the neutron fluence with the conversion coefficient hΦ(E). Using a mean value of  
hΦ = 300 pSv·cm2 [12] we obtain a dose value of 16 mSv per treatment-Gy or 5.4 mSv per 
treatment-GyE. 
Using the Wide-Energy Neutron Detection Instrument (WENDI-II) [13] the neutron dose 
and angular distribution was obtained in independent measurements under the same 
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above. At small angles below 10° the dose values obtained from the WENDI measurements are 
higher by about a factor of 2 compared to the dose values estimated from the fluence 
measurements. This might be explained by the response of WENDI to high-energy protons and 
alpha particles which are also present in the particle field and can not be easily corrected for.  
 
4. Comparison of neutron doses in proton and carbon ion therapy 
In table 2 dose contributions of secondary neutrons obtained from the present work with 
12C ions at GSI and from measurements at the proton therapy facility at PSI (Switzerland) [14] 
are compared. Both treatment units use scanning beam delivery systems. Although the yield of 
fast neutrons is much higher for 12C ions than for protons the neutron doses per treatment-GyE 
are not very different because of the much lower number of 12C ions needed to produce the same 
biologically effective dose as protons.  
 







[mSv per treatment-GyE] 
GSI [7] 12C (200) H2O (12.78) 0.54 ± 20% 5.4 ± 20%  (scanning) 
Schneider [14] p (177) H2O (30.1) (0.025) 2.3  ± 30% (scanning) 
* Neutron dose expected in healthy tissue of the patient in the non-treated volume for a medium-sized 
target 
  
Table 2: Comparison of neutron yields and neutron doses in 12C ion and proton 
radiotherapy for scanning beam delivery systems. The yield number given in 
parentheses was recalculated from the dose. 
 
For passive beam delivery systems, where secondary neutrons are produced mainly by 
interactions of the primary beam with collimators, range shifters and other elements located in 
front of the patients, the neutron dose varies significantly with the configuration of the beam 
modifying equipment. This was examined experimentally by Yan et al. [15] for the medical 
beam line at the Harvard Cyclotron Laboratory. They found neutron dose equivalent values of 
typically 1-5 mSv/Gy at 50 cm distance from isocenter.   
Monte Carlo calculations performed by Agosteo et al. [16] for the proton therapy beam 
lines at PSI (active scanning) and at iThemba LABS South Africa (passive system) confirm the 
experimental results by Schneider et al. [14] and Binns et al. [17]. The calculations indicate a 
factor of 10 higher secondary dose for the passive beam delivery system which seems to 
originate predominantly from neutrons generated in the last collimator. 
   
In conclusion, the present work has shown that the dose contribution caused by secondary 
neutrons in carbon ion radiotherapy is of the order of 1% of the treatment dose and much lower 
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calculations are planned to investigate the dose deposition of secondary fragments, in particular 
in regions outside of the planned treatment volume.  
 
References 
[1] H. Iwase et al., Calculation of secondary neutron fields generated by high-energy heavy-ion 
reactions using the Monte-Carlo code PHITS, contribution to this conference.  
[2] W. Schimmerling et al., Fragmentation of 670 A MeV Neon 20 as a function of depth in water, 
Radiat. Res. 120 (1989) 36. 
[3] I. Schall I. et al., Charge-changing nuclear reactions of relativistic light-ion beams (5 ≤ Z ≤ 10) 
passing through thick absorbers, Nucl. Instr. and Meth. B117 (1996) 221. 
[4] N. Matsufuji et al., Spatial fragment distribution from a therapeutic pencil-like carbon beam in 
water, Phys. Med. Biol. 50 (2005) 3393. 
[5] R.A. Cecil et al., Neutron angular and energy distributions from 710-MeV alphas stopping in 
water, carbon  and lead and 640 MeV-alphas stopping in lead, Phys. Rev. C21 (1980) 2471. 
[6] T. Kurosawa et al., Measurements of secondary neutrons produced from thick targets 
bombarded by high-energy helium and carbon ions, Nucl., Sci. Eng. 132 (1999) 30. 
[7] K. Gunzert-Marx et al., Fast neutrons produced by nuclear fragmentation in treatment 
irradiations with 12C beam, Rad. Prot. Dosim. 110 (2004) 595. 
[8] K. Gunzert-Marx et al., Response of a BaF2 scintillation detector to quasi-monoenergetic fast 
neutrons in the range of 45 to 198 MeV, Nucl. Instrum. Meth. A536 (2005) 146.  
[9] M. Krämer, O. Jäkel, T. Haberer, G. Kraft, D. Schardt, U. Weber, Treatment planning for heavy-
ion radiotherapy: physical beam model and dose optimization, Phys. Med. Biol. 45 (2000) 3299. 
[10] M. Krämer and M. Scholz, Treatment planning for heavy-ion radiotherapy: calculation and 
optimization of biologically effective dose, Phys. Med. Biol. 45 (2000) 3319. 
[11] I. Pshenichnov et al., Neutrons from fragmentation of light nuclei in tissue-like media: a study 
with the GEANT4 toolkit, Phys. Med. Biol. 50 (2005) 5493. 
[12] A. Ferrari, M. Pellicioni, Fluence to dose equivalent conversion data and effective quality 
factors for high energy neutrons, Rad. Prot. Dosim. 76 (1998) 215. 
[13] R.H. Olscher et al., WENDI: An improved neutron rem meter, Health Physics 79 (2000) 170. 
[14] U. Schneider et al., Secondary neutron dose during proton therapy using spot scanning, Int. J. 
Radiation Oncology Biol. Phys. 53 (2002) 244. 
[15] X. Yan, U. Titt, A.M. Koehler, W.D. Newhauser, Measurement of neutron dose equivalent to 
proton therapy patients outside of the proton radiation field, Nucl. Instrum. Meth. A476 (2002) 
429. 
[16] S. Agosteo et al., Secondary neutron and photon dose in proton therapy, Radiother. Oncol. 48 
(1998) 293. 
[17] P.J. Binns, J.H. Hough, Secondary dose exposures during 200 MeV proton therapy, Rad. Prot. 
Dosim. 70 (1997) 441. 
 
 
 
 
 
 
 
